Kwag Eunbin, Li Xiaotong, Garland Sheila, Bryl Karolina, Taylor Lauren, Li Qing S, Amann Lindsay, Mao Jun J, McConnell Kelly M
Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Department of Psychology and Oncology, Memorial University, St. John's, Newfoundland and Labrador, Canada.
Integr Med Res. 2025 Dec;14(4):101213. doi: 10.1016/j.imr.2025.101213. Epub 2025 Aug 7.
Anxiety and insomnia frequently co-occur among cancer survivors and are strongly interconnected, yet no widely accepted intervention simultaneously targets both symptoms.
Data were drawn from a dual-center, parallel-group, randomized, comparative effectiveness trial evaluating acupuncture versus CBT-I for insomnia. Seventy-six participants with baseline Hospital Anxiety and Depression Scale-Anxiety (HADS-A) scores of ≥8 were included. Both interventions were administered over eight weeks, with follow-up until 20 weeks. Anxiety was assessed at baseline, week 8, and week 20 using HADS-A. A linear mixed-effects model was used to examine mean change in HADS-A scores. Additionally, responder analyses were conducted, with insomnia and anxiety responders defined as patients demonstrating clinically meaningful improvements in either outcome by week 8.
Both CBT-I and acupuncture significantly reduced HADS-A scores at week 8 (CBT-I: -3.75; acupuncture: -3.14) and week 20 (CBT-I: -3.05; acupuncture: -2.66) compared to baseline (all p < 0.001). There was no between-group difference (p=0.85). In responder analyses, CBT-I showed greater anxiety reduction in insomnia responders (-4.62) than non-responders (-0.45), at both time points (week 8: =0.0046; week 20: =0.038). In the acupuncture group, the difference in anxiety reduction between insomnia responders (-3.96) and non-responders (-1.58) was not statistically significant.
Both acupuncture and CBT-I effectively manage comorbid anxiety and insomnia in cancer survivors. Acupuncture may address these symptoms independently, while CBT-I may improve them in an interconnected manner.
ClinicalTrials.gov registration (NCT02356575).
焦虑和失眠在癌症幸存者中经常同时出现且联系紧密,但尚无被广泛接受的能同时针对这两种症状的干预措施。
数据取自一项双中心、平行组、随机、比较疗效试验,该试验评估针刺疗法与认知行为疗法治疗失眠(CBT-I)的效果。纳入了76名基线医院焦虑抑郁量表-焦虑(HADS-A)评分≥8的参与者。两种干预措施均持续八周,随访至20周。在基线、第8周和第20周使用HADS-A评估焦虑情况。采用线性混合效应模型检查HADS-A评分的平均变化。此外,进行了反应者分析,将失眠和焦虑反应者定义为在第8周时在任一结局上显示出具有临床意义改善的患者。
与基线相比,CBT-I和针刺疗法在第8周(CBT-I:-3.75;针刺疗法:-3.14)和第20周(CBT-I:-3.05;针刺疗法:-2.66)时均显著降低了HADS-A评分(所有p<0.001)。组间无差异(p = 0.85)。在反应者分析中,在两个时间点(第8周:p = 0.0046;第20周:p = 0.038),CBT-I在失眠反应者中比非反应者显示出更大的焦虑减轻幅度(-4.62比-0.45)。在针刺疗法组中,失眠反应者(-3.96)和非反应者(-1.58)之间的焦虑减轻差异无统计学意义。
针刺疗法和CBT-I均能有效管理癌症幸存者中共存的焦虑和失眠。针刺疗法可能独立解决这些症状,而CBT-I可能以相互关联的方式改善这些症状。
ClinicalTrials.gov注册(NCT02356575)。